Shaida Khan, D.O. Titles and Appointments Medical Director of Neurology, Parkland Hospital Associate Professor School Medical School Department Neurology You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Joined UT Southwestern: 2017 Clinical Interests: Shaida Khan, D.O. serves as the Medical Director of the Neurology Ambulatory Clinic at Parkland Hospital. She specializes in evaluating, diagnosing, and treating autoimmune peripheral neurological disorders and neuromuscular disorders such as myasthenia gravis, chronic inflammatory demyelinating polyneuropathy (CIDP), peripheral neuropathy, inflammatory myopathies, muscular dystrophy, and amyotrophic lateral sclerosis (ALS). Research: Dr. Khan has research interests in myasthenia gravis and muscular dystrophy. She is the site investigator for several clinic trials for some of the promising therapies in myasthenia gravis. She previously served as the Vice Chair of the Women’s Issues in Neurology Section for the American Academy of Neurology (AAN). Leadership: Dr. Khan was awarded a three-year grant from the Fichtenbaum Charitable Trust to improve the quality of care, education, and research in the myasthenia gravis population of Dallas County, and in 2021 she established the Myasthenia Gravis Clinic at Parkland. She was the lead physician working alongside Parkland Hospital Leadership and the Business & Development Office to establish the first neurology multidisciplinary clinic at Parkland, transitioning care for patients with Duchenne Muscular Dystrophy and Spinal Muscular Atrophy from pediatric to adult subspecialty care. Affiliations & Awards: She has received the honorable Trephined Cranium Teaching Award for three years in recognition of outstanding teaching to the neurology resident trainees. She was awarded the Fred Baskin Young Investigator Award for her research in muscular dystrophy, the Roger Rosenberg Fellow of the Year Award, and received the UT Southwestern Wellstone MDCRC training grant from the NIH. Elected by UT Southwestern medical students, she attained distinction as a member of the Alpha Omega Alpha Honor Society in 2014. She has received several awards for her work as a clinician, educator, and young investigator. She is a member of several academic leadership, hospital, and student advisory committees. She is a mentor for several quality improvement projects through her role as Medical Director of the Parkland Neurology clinic. Background: Dr. Khan earned her medical degree (D.O.) at UNT Health Science Center in Fort Worth, TX. She completed her neurology residency and neuromuscular medicine fellowship at UT Southwestern Medical Center. Dr. Khan is board certified in neurology by the American Board of Psychiatry and Neurology and has subspecialty board certification in Neuromuscular medicine. Education Medical School UNT Health Science Center at Fort Worth (2012) Residency UT Southwestern Medical Center (2016), Neurology Fellowship UT Southwestern Medical Center (2018), Neuromuscular Disease Research Interest Muscular Dystrophy Myasthenia Gravis Quality Improvement Publications Evaluation of the impact of neurology electronic consults (e-consults): Experiences of a neurology resident clinic in a safety-net hospital Tardo L, Hirczy S, Blackburn K, Mejia M, Salter A, Huynh M, Khan S Journal of Telemedicine and Telecare 2025 Oct 31 1270-1277 Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb, open-label study Freimer M, Desai U, Govindarajan R, Kang MK, Khan S, Khatri B, Levine T, Macwan S, Shieh PB, Weiss MD, Bloemers J, Boroojerdi B, Delicha EM, Lavrov A, Singh P, Howard JF Therapeutic Advances in Neurological Disorders 2025 Jan 18 Subcutaneous batoclimab in generalized myasthenia gravis: Results from a Phase 2a trial with an open-label extension Nowak RJ, Breiner A, Bril V, Allen JA, Khan S, Levine T, Jacobs DH, Sahagian G, Siddiqi ZA, Xu J, Macias WL, Benatar M Annals of Clinical and Translational Neurology 2024 Jan 11 194-206 Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study Author Collaboration RS, Howard JF, Bresch S, Genge A, Hewamadduma C, Hinton J, Hussain Y, Juntas-Morales R, Kaminski HJ, Maniaol A, Mantegazza R, Masuda M, Sivakumar K, Śmiłowski M, Utsugisawa K, Vu T, Weiss MD, Zajda M, Boroojerdi B, Brock M, de la Borderie G, Duda PW, Lowcock R, Vanderkelen M, Leite MI, Sembinelli D, Teitelbaum J, Nicolle M, Bernard E, Svahn J, Spinazzi M, Stojkovic T, Demeret S, Weiss N, Le Guennec L, Messai S, Tranchant C, Nadaj-Pakleza A, Chanson JB, Suliman M, Zaidi L, Tard C, Lecointe P, Zschüntzsch J, Schmidt J, Glaubitz S, Zeng R, Scholl M, Kowarik M, Ziemann U, Khan S The Lancet Neurology 2023 May 22 395-406 Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy Author Collaboration tV, Korb M, Peck A, Alfano LN, Berger KI, James MK, Ghoshal N, Healzer E, Henchcliffe C, Khan S, Mammen PP, Patel S, Pfeffer G, Ralston SH, Roy B, Seeley WW, Swenson A, Mozaffar T, Weihl C, Kimonis V, Fanganiello R, Lee G, Mahoney RP, Diaz-Manera J, Evangelista T, Freimer M, Lloyd TE, Keung B, Kushlaf H, Milone M, Needham M, Palmio J, Stojkovic T, Villar-Quiles RN, Wang LH, Wicklund MP, Singer FR, Jones M, Miller BL, Ahmad Sajjadi S, Obenaus A, Geschwind MD, Al-Chalabi A, Wymer J, Chen N, Kompoliti K, Wang SC, Boissoneault CA, Cruz-Coble B, Garand KL, Rinholen AJ Orphanet Journal of Rare Diseases 2022 Dec 17 Autosomal Dominant ANO5-Related Disorder Associated With Myopathy and Gnathodiaphyseal Dysplasia Shaibani A, Khan S, Shinawi M Neurology: Genetics 2021 Aug 7 Brody Myopathy Presenting as Recurrent Rhabdomyolysis Bergstrom C, Remz M, Khan S, McNutt M American Journal of Medicine 2021 Jul 134 e429-e430 New patient access via telehealth in neuromuscular medicine during COVID-19 Khan S, Kramer A, McIver J, Cady L, Trivedi JR Work 2021 69 715-719 Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients with Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial Howard JF, Nowak RJ, Wolfe GI, Freimer ML, Vu TH, Hinton JL, Benatar M, Duda PW, MacDougall JE, Farzaneh-Far R, Kaminski HJ, Barohn R, Dimachkie M, Pasnoor M, Farmakidis C, Liu T, Colgan S, Benatar MG, Bertorini T, Pillai R, Henegar R, Bromberg M, Gibson S, Janecki T, Elsheikh B, Matisak P, Genge A, Guidon A, David W, Habib AA, Mathew V, Mozaffar T, Hewitt W, Barnett D, Sullivan P, Ho D, Traub RE, Chopra M, Aly R, Bayat E, Abu-Rub M, Khan S, Lange D, Holzberg S, Khatri B, Lindman E, Olapo T, Sershon LM, Lisak RP, Bernitsas E, Jia K, Malik R, Lewis-Collins TD, Nicolle M, Sharma A, Roy B, Nye J, Pulley M, Berger A, Shabbir Y, Sachdev A, Patterson K, Siddiqi Z, Sivak M, Bratton J, Small G, Kohli A, Fetter M, Lam L, Harvey B, Silvestri N, Patrick K, Zakalik K, Pontius A, Hoarty M JAMA neurology 2020 May 77 582-592 A 59-Year-Old Woman with Subacute Lower Limb Weakness and Painful Paresthesia Khan S, Cai C 2019 Jan 311-317 Results 1-10 of 11 1 2 Next Last Books Featured Books A 59-Year-Old Woman with Subacute Lower Limb Weakness and Painful Paresthesia. In A Case-Based Guide to Neuromuscular Pathology Khan S, Cai C (2019). Springer Honors & Awards Trephined Cranium Teaching Award (2023) Trephined Cranium Teaching Award (2021) Trephined Cranium Teaching Award (2020) 2017 AAN Fellow Scholarship to the Annual Meeting (2017) Fred Baskin Young Investigator Award (2017) Roger Rosenberg Fellow of the Year Award (2016-2017) UTSW Wellstone MDCRC Training GrantNIH grant (2016-2018) Chief Resident (2015-2016) Professional Associations/Affiliations Alpha Omega Alpha Honor Society (2013) American Academy of Neurology (2012) Dallas County Medical Society (2020) Texas Neurological Society (2018)
